Managing Pediatric Asthma: Choosing the Next Step in Treatment

When treating pediatric asthma, it is important to follow guidelines to ensure the best possible outcomes for the patient. According to the 2019 SIGN/BTS guidelines, the next step after low-dose inhaled corticosteroid (ICS) should be to add a long-acting beta agonist (LABA) or leukotriene receptor antagonist (LTRA) in addition to ICS. However, it is important to note that the NICE guidelines differ in that LTRA is recommended before LABA.

If the patient does not respond adequately to LABA and a trial of LTRA does not yield benefit, referral to a pediatrician is advised. Increasing the dose of ICS should only be considered after the addition of LTRA or LABA.

It is crucial to never stop ICS therapy, as adherence to therapy is a guiding principle in managing pediatric asthma. LABAs should never be used alone without ICS, as this has been linked to life-threatening asthma exacerbations. Always follow guidelines and consult with a pediatrician for the best possible treatment plan.

According to UK resuscitation guidelines, the first step in neonatal resuscitation is to dry the baby, remove any wet towels, and note the time. Within 30 seconds, an Apgar assessment should be conducted to evaluate the baby’s tone, breathing, and heart rate. If the baby is gasping or not breathing, the airway should be opened, and 5 inflation breaths should be given within 60 seconds. If there is no increase in heart rate, chest movement should be checked. If the chest is not moving, the head position should be rechecked, and other airway maneuvers should be considered. Inflation breaths should be repeated, and a response should be looked for. If there is still no increase in heart rate, chest compressions should be started with 3 compressions to each breath. The heart rate should be reassessed every 30 seconds. If the heart rate is still slow or undetectable, venous access and drugs should be considered. Atropine and intubation are later steps in the management.

The Apgar score is a tool used to evaluate the health of a newborn baby. It is recommended by NICE to be assessed at 1 and 5 minutes after birth, and again at 10 minutes if the initial score is low. The score is based on five factors: pulse, respiratory effort, color, muscle tone, and reflex irritability. A score of 0-3 is considered very low, 4-6 is moderate low, and 7-10 indicates that the baby is in good health. The score helps healthcare professionals quickly identify any potential issues and provide appropriate care.

Overview of Spinal Cord Syndromes

Spinal cord syndromes are a group of neurological disorders that affect the spinal cord and its associated nerves. These syndromes can be caused by various factors, including trauma, infection, and degenerative diseases. Here are some of the most common spinal cord syndromes:

Hemisection of the Cord (Brown-Sequard Syndrome)
This syndrome is characterized by ipsilateral loss of vibration and proprioception, as well as ipsilateral hemiplegia. On the other hand, there is contralateral loss of pain and temperature sensation. Hemisection of the cord is usually caused by a stab injury.

Central Cord Syndrome
Central cord syndrome causes bilateral weakness of the limbs, with the upper limbs being more affected than the lower extremities. This is because the upper limbs are represented medially in the corticospinal tracts.

Anterior Cord Syndrome
In anterior cord syndrome, proprioception, vibratory sense, and light touch are preserved. However, there is bilateral weakness and loss of pain and temperature sensation due to involvement of the spinothalamic tracts.

Posterior Cord Syndrome
Posterior cord syndrome is characterized by loss of vibratory sense and proprioception below the level of the lesion, as well as total sensory loss at the level of the lesion.

Cauda Equina Syndrome
Cauda equina syndrome is caused by compressive lesions at L4/L5 or L5/S1. Symptoms include asymmetric weakness, saddle anesthesia, decreased reflexes at the knee, and radicular pain. Bowel and bladder retention may develop as late complications.

In conclusion, understanding the different types of spinal cord syndromes is crucial in diagnosing and treating patients with neurological disorders.

Bisphosphonates are commonly used to prevent bone loss and treat conditions such as Paget’s disease, hypercalcaemia, and metastatic bone disease. However, they can cause side-effects such as oesophagitis, gastritis, and osteonecrosis of the jaw. Patients are advised to take bisphosphonates with a full glass of water and remain upright for 30-60 minutes after ingestion to reduce the risk of upper gastrointestinal symptoms. Other side-effects include fever, myalgias, and arthralgias, which are more common with intravenous bisphosphonate therapy. Hypercalcaemia is not a common side-effect, and bisphosphonates can actually help treat it. Atrial fibrillation and femoral shaft fractures are not commonly associated with bisphosphonate use, but osteonecrosis of the jaw is a rare but well-known side-effect that can be reduced with antibiotic prophylaxis before dental interventions.

An ileostomy is a type of stoma that is created to prevent the skin from being exposed to the enzymes in the small intestine. This is commonly seen in patients with Crohn’s disease, which affects the entire gastrointestinal tract. While the location of the stoma may vary, it is the structure of the stoma itself that determines whether it is an ileostomy or a colostomy. In contrast, a tracheostomy is an opening in the trachea, while a nephrostomy is an opening in the kidneys that is used to drain urine into a bag. A urostomy is another type of stoma that is used to divert urine from the urinary system into a bag, but it differs from an ileostomy in that it involves the use of an ileal conduit.

Abdominal stomas are created during various abdominal procedures to bring the lumen or contents of organs onto the skin. Typically, this involves the bowel, but other organs may also be diverted if necessary. The type and method of construction of the stoma will depend on the contents of the bowel. Small bowel stomas should be sprouted to prevent irritant contents from coming into contact with the skin, while colonic stomas do not require spouting. Proper siting of the stoma is crucial to reduce the risk of leakage and subsequent maceration of the surrounding skin. The type and location of the stoma will vary depending on the purpose, such as defunctioning the colon or providing feeding access. Overall, abdominal stomas are a necessary medical intervention that requires careful consideration and planning.

CMV and Hodgkin’s Lymphoma

CMV is a virus that typically affects individuals with a weakened immune system. While a CD4 count of less than 400 is often used as a threshold for diagnosis, CMV disease is rare in HIV-positive patients unless their CD4 count drops below 50. A positive PCR result can confirm a diagnosis of CMV, which should be treated with ganciclovir. On the other hand, Hodgkin’s lymphoma is a type of cancer that is characterized by the presence of Reed-Sternberg cells, which have a distinct owl’s eye appearance.

In summary, CMV and Hodgkin’s lymphoma are two distinct medical conditions that require different approaches to diagnosis and treatment. While CMV is an opportunistic virus that affects immunocompromised individuals, Hodgkin’s lymphoma is a type of cancer that can affect anyone. By the key differences between these two conditions, healthcare professionals can provide more effective care to their patients.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a long-term inflammatory condition that affects the joints and surrounding tissues. The exact cause of RA is unknown, but it is believed to be an autoimmune disorder where the body’s immune system mistakenly attacks its own tissues. The disease typically affects multiple joints, causing pain, stiffness, and swelling. Over time, the condition can progress and lead to joint deformity and limited mobility. This chronic condition can significantly impact a person’s quality of life, making it important to seek early diagnosis and treatment.

The Sites of Haematopoiesis in the Fetus and Adult

Haematopoiesis, the process of blood cell formation, occurs in various sites throughout fetal development and in adults. The dominant site of haematopoiesis changes as the fetus develops and bones are formed. Here are the different sites of haematopoiesis and their significance:

Bone Marrow: From four months into childhood and adulthood, bone marrow becomes the primary source of hematopoiesis. Red blood cells and immune effector cells are derived from pluripotent haematopoietic cells, which are first noted in blood islands of the yolk sac. By 20 weeks, almost all of these cells are produced by the bone marrow.

Yolk Sac: Haematopoiesis begins in the yolk sac and in angiogenic cell clusters throughout the embryonic body. This involves the formation of nucleated red blood cells, which differentiate from endothelial cells in the walls of blood vessels. Yolk sac haematopoiesis peaks at about one month and becomes insignificant by three months.

Liver: By the sixth week, the fetal liver performs haematopoiesis. This peaks at 12-16 weeks and continues until approximately 36 weeks. Haematopoietic stem cells differentiate in the walls of liver sinusoids. In adults, there is a reserve haematopoietic capacity, especially in the liver.

Spleen: The spleen is a minor site of haematopoiesis, being active between the third and sixth months.

Lymph Nodes: Lymph nodes are not a significant site of haematopoiesis.

In patients with certain conditions, such as haemolytic anaemia or myeloproliferative disease, hepatic haematopoiesis may be reactivated, leading to hepatomegaly. Understanding the different sites of haematopoiesis is important for understanding blood cell formation and certain medical conditions.

Calcium supplementation should only be prescribed alongside bisphosphonate treatment for osteoporosis if the patient’s dietary intake is insufficient.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

Huntington’s Disease

Huntington’s disease is a genetic disorder that is inherited through autosomal means. It is caused by an expanded CAG trinucleotide repeat on chromosome 4’s short arm. The disease is characterized by a gradual decline in cognitive function and increasingly erratic movements known as choreiform movements. Symptoms usually manifest between the ages of 30 and 50. Genetic testing is now available to accurately diagnose the disease. The average life expectancy after the onset of symptoms is approximately 15 years.

In summary, Huntington’s disease is a debilitating genetic disorder that affects cognitive function and movement. It is caused by an expanded CAG trinucleotide repeat on chromosome 4’s short arm. Symptoms typically appear in middle age, and genetic testing is now available to diagnose the disease accurately. Unfortunately, the average life expectancy after the onset of symptoms is relatively short.